Tenet Healthcare Corporation THC delivered third-quarter 2019 adjusted net income of 58 cents per share, beating the Zacks Consensus Estimate by 107.1% on the back of volume growth and better revenues. Moreover, the bottom line shot up 100% year over year. Quarterly Operational Update Net operating revenues came in at $4.5 billion, up 1.8% year over year. Additionally, the top line beat the Zacks Consensus Estimate by 2.4% on contributions from the Hospital & Other and Ambulatory segments. Hospital segment’s same-hospital admissions were up 3.6% year over year. Quarterly Segment Details Hospital & Other Net operating revenues in the Hospital Operations and Other segment totaled $3.8 billion, up 2.3% year over year. This upside is mainly attributable to revenue growth on same-hospital basis. However, the same was partly offset by hospital divestitures. On same-hospital basis, patient revenues were $3.56 billion, up 5.8% year over year. Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) was $343 million, up 7.1% year over year. Ambulatory Segment The Ambulatory segment generated net operating revenues of $522 million, up 4% year over year. Additionally, the segment reported adjusted EBITDA of $207 million, up 13.7% year over year. Conifer Segment Conifer’s revenues decreased 9.4% from the prior-year quarter’s level to $336 million. This was mainly due to the company’s client attrition following certain divestitures. The segment’s adjusted EBITDA of $90 million was up 11.1% year over year.
Financial Position As of Sep 30, 2019, Tenet Healthcare had cash and cash equivalents of $314 million, down 23.6% from the number at 2018 end. The company exited the third quarter with $14.8 billion of long-term debt, up 1.5% from the 2018-end level. Net cash provided by operating activities for the first nine months of 2019 was $713 million, down 10.8% year over year. 2019 Outlook Post third-quarter results, the company revised its guidance. Revenues are now expected between $18.350 billion and $18.550 billion compared with the earlier view of $18-$18.4 billion. Adjusted earnings per share are now projected between $2.25 and $2.91. Adjusted EBITDA is estimated between $2.650 billion and $2.750 billion. Tenet Healthcare anticipates adjusted free cash flow of $600-$800 million. While net cash provided by operating activities is predicted between $1.045 billion and $1.325 billion. Q419 Guidance Following third-quarter results, the company provided an outlook for the fourth quarter. Tenet Healthcare now anticipates revenues in the range of $4.678-$4.878 billion for the current quarter. The company forecasts adjusted EBITDA between $749 million and $849 million. Adjusted earnings per share from continuing operations are likely to vary between 57 cents and $1.23. Zacks Rank and Performance of Other Players Tenet Healthcare sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. Among other players from the medical sector, having already reported third-quarter earnings, the bottom-line results of UnitedHealth Group Incorporated UNH, Anthem Inc. ( ANTM Quick Quote ANTM - Free Report) and Centene Corporation CNC topped the respective Zacks Consensus Estimate. More Stock News: This Is Bigger than the iPhone! It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market. Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020. Click here for the 6 trades >>